Publications

Clewell HJ, Teeguarden J, McDonald T, Sarangapani R, Lawrence G, Covington T, Gentry R, Shipp A. 2002. Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit Rev Toxicol 32(5):329–389.

Hofelt CS, Honeycutt M, McCoy JT, Haws LC. 2001. Development of a metabolism factor for polycyclic aromatic hydrocarbons for use in multipathway risk assessments for hazardous waste combustion facilities. Reg Toxicol Pharmacol 33(1):60-65; doi: 10.1006/rtph.2000.1438.

Gentry PR, Covington TR, Andersen ME, Clewell HJ. 2002. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol 36:51–68.

Strobel HW, Thompson CM, Antonovic L. 2001. Cytochromes P450 in brain: Function and significance. Curr Drug Metabol 2(2):199–214; doi: 10.2174/1389200013338577.

Booth RG, Moniri NH, Bakker RA, Choksi NY, Nix WB, Timmerman H, Leurs R. 2002. A novel phenylaminotetralin radioligand reveals a sub-population of histamine H1 receptors. J Pharmacol Exper Therapeut 302(1):328–336; doi: 10.1124/jpet.302.1.328.

Love AH, Hunt JR, Roberts ML, Southon JR, Chiarappa-Zucca ML, Dingley KH. 2002. Use of tritium accelerator mass spectrometry for tree ring analysis. Environ Sci Technol 36(13):2848–2852; doi: 10.1021/es015837o. PMID: 12144257.

Williams KE, Carver TA, Miranda JJ, Kautiainen A, Vogel JS, Dingley K, et al. 2002. Attomole detection of in vivo protein targets of benzene in mice: Evidence for a highly reactive metabolite. Mol Cell Proteomics 1(11):885–895; doi: 10.1074/mcp.m200067-mcp200. PMID: 12488464.

Nordyke RJ. 2002. Determinants of PHC productivity and resource utilization: A comparison of public and private physicians in Macedonia. Health Pol 60(1):67-96; doi: 10.1016/s0168-8510(01)00192-0. PMID: 11879946.

Lea IA, Widgren EE, O’Rand MG. 2002. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception. Vaccine 20(11–12):1515–1523; doi: 10.1016/S0264-410X(01)00514-X.

Tao L, Wadsworth S, Mercer J, Mueller C, Lynn K, Siekierka J, August A. 2002. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T- cells. Biochem J 363(Pt 1):175–182; doi: 10.1042/0264-6021:3630175. PMID: 11903060.

Nordyke RJ, Peabody JW. 2002. Market reforms and public incentives: Finding a balance in the Republic of Macedonia. Soc Sci Med 54(6):939-53; doi: 10.1016/s0277-9536(01)00067-3. PMID: 11996027.

Clewell HJ, Gentry PR, Gearhart JM, Covington TR, Banton MI, Andersen ME. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci 63(2):160–172; doi: 10.1093/toxsci/63.2.160.

Ebi K, Exuzides KA, Lau E, Kelsh MA, Barnstorm A. 2001. Association of normal weather periods and El Nino events with viral pneumonia hospitalization in females, California 1983–1998. Amer Pub Health Assoc J 91(8):1200–1208; doi: 10.2105/ajph.91.8.1200. PMID: 11499104.

Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol Sci 59(1):37–48; doi: 10.1093/toxsci/59.1.37.

Setzer RW, Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol Sci 59(1):49–58; doi: 10.1093/toxsci/59.1.49.

Rogers JM, Hunter ES III. 2001. Toxicological highlight-Redox redux: A closer look at conceptual low molecular weight thiols. Toxicol Sci 62(1):1–3; doi: 10.1093/toxsci/62.1.1.

Huang Y-S, Held G, Andrews JE, Rogers JM. 2001. 14C-methanol incorporation into DNA and specific proteins of organogenesis-stage mouse embryos in vitro. Reprod Toxicol 15:429–435; doi: 10.1016/s0890-6238(01)00144-7.

Leazer TM, Rogers JM. 2001. Role of the acute phase response and tissue necrosis factor alpha in the developmental toxicity of lipopolysaccharide in the CD-1 mouse. Reprod Toxicol 16(2):173–179; doi: 10.1016/S0890-6238(02)00011-4.

Kolanz ME, Madl AK, Kelsh MA, Kent MS, Kalmes RM, Paustenbach DJ. 2001. A comparison and critique of historical and current exposure assessment methods for beryllium: Implications for evaluating risk of chronic beryllium disease. Appl Occup Environ Hyg 16(5):593–614; doi: 10.1080/10473220119613. PMID: 11370938.

Deubner D, Kelsh MA, Shum M, Maier L, Kent MS, Lau E. 2001. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg 16(5):579–592; doi: 10.1080/104732201750169697. PMID: 11370937.